COR Q3 2025 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q3 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$80.7B+8.7% YoY

Gross Profit

$2.7B3.3% margin

Operating Income

$986M1.2% margin

Net Income

$687M0.9% margin

EPS (Diluted)

$3.52

QoQ Revenue Growth

+6.9%

Cash Flow

Operating Cash Flow

$109M

Free Cash Flow

-$74M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$74.0B

Total Liabilities

$71.7B

Stockholders' Equity

$2.0B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80.7B	$74.2B	+8.7%
Gross Profit	$2.7B	$2.1B	+27.4%
Operating Income	$986M	$703M	+40.1%
Net Income	$687M	$483M	+42.2%

Revenue Segments

Pharmaceutical Distribution

$71.4B89%

International Healthcare Solutions

$7.8B10%

Animal Health

$1.5B2%

Geographic Segments

U.S. Healthcare Solutions

$72.9B90%

International Healthcare Solutions

$7.8B10%